Skip to content
DefDex

Federal award

NOVEOME BIOTHERAPEUTICS INC

N6264513C4014

Contract

Obligated and Ceiling

Obligated (net)
$53,076,259.00
Ceiling (potential value, not spending)
$53,076,259.00
Current value
$53,076,259.00
Gross positive obligations
$53,178,859.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
NOVEOME BIOTHERAPEUTICS INC · D35WXDLB8K59
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
NOVEOME BIOTHERAPEUTICS INC · D35WXDLB8K59
Awarding agency
Department of War · sub-agency 1700 · office N62645
Funding agency
Department of War · sub-agency 1700
Product or service (PSC)
AN93 · R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT)
Industry (NAICS)
541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PIID
N6264513C4014
Award type code
D
Actions
20 · Apr 19, 2013 to Oct 12, 2017
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History20

Award actions
DateFYModAction typeObligationCompany in company totals
Oct 12, 2017FY2018P00019B$0.00
—
Apr 21, 2017FY2017P00018B$0.00
—
Jan 31, 2017FY2017P00017C$1,650,000.00
—
Aug 30, 2016FY2016P00016B$8,005,000.00
—
Jul 28, 2016FY2016P00015G$1,592,540.00
—
May 26, 2016FY2016P00014V$0.00
—
Mar 10, 2016FY2016P00013B−$102,600.00
—
Oct 15, 2015FY2016P00012C$1,743,909.00
—
Aug 26, 2015FY2015P00011B$9,370,876.00
—
Jul 22, 2015FY2015P00010B$540,000.00
—
May 7, 2015FY2015P00009M$0.00
—
Dec 22, 2014FY2015P00008B$0.00
—
Aug 11, 2014FY2014P00007M$0.00
—
Jun 4, 2014FY2014P00006G$9,894,778.00
—
Mar 13, 2014FY2014P00005C$107,000.00
—
Mar 7, 2014FY2014P00004M$0.00
—
Oct 29, 2013FY2014P00003G$9,983,691.00
—
Sep 30, 2013FY2013P00002M$0.00
—
Aug 22, 2013FY2013P00001C$822,065.00
—
Apr 19, 2013FY20130—$9,469,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.